{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T20:11:42Z","timestamp":1780344702054,"version":"3.54.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["R21TW011785"],"award-info":[{"award-number":["R21TW011785"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008673","name":"Center for AIDS Research, University of California, San Diego","doi-asserted-by":"publisher","award":["P30 AI036214"],"award-info":[{"award-number":["P30 AI036214"]}],"id":[{"id":"10.13039\/100008673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CIHR PJH-175382"],"award-info":[{"award-number":["CIHR PJH-175382"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA023356"],"award-info":[{"award-number":["T32DA023356"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA049644-02S1"],"award-info":[{"award-number":["R01DA049644-02S1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA043421"],"award-info":[{"award-number":["K01DA043421"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In Kyrgyzstan and other Eastern European and Central Asian countries, injection drug use and HIV-related intersectional stigma undermines HIV prevention efforts, fueling a rapidly expanding HIV epidemic. The Kyrgyzstan InterSectional Stigma (KISS) Injection Drug Use Cohort is the first study designed to assess the impact of drug use, methadone maintenance treatment (MMT) and HIV stigma experiences among people who inject drugs (PWID) on HIV prevention service utilization.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Adult PWID were recruited from Bishkek city and the surrounding rural Chuy Oblast region in northern Kyrgyzstan via modified time location sampling and snowball sampling. All participants completed a baseline rapid HIV test and interviewer-administered survey. A subsample of participants were prospectively followed for three months and surveyed to establish retention rates for future work in the region. Internal reliability of three parallel stigma measures (drug use, MMT, HIV) was evaluated. Descriptive statistics characterize baseline experiences across these three stigma types and HIV prevention service utilization, and assess differences in these experiences by urbanicity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The KISS cohort (<jats:italic>N<\/jats:italic>\u2009=\u2009279, 50.5% Bishkek, 49.5% Chuy Oblast) was mostly male (75.3%), ethnically Russian (53.8%), median age was 40\u00a0years old (IQR 35\u201346). Of the 204 eligible participants, 84.9% were surveyed at month 3. At baseline, 23.6% had a seropositive rapid HIV test. HIV prevention service utilization did not differ by urbanicity. Overall, we found 65.9% ever utilized syringe service programs in the past 6\u00a0months, 8.2% were utilizing MMT, and 60.8% met HIV testing guidelines. No participants reported PrEP use, but 18.5% had heard of PrEP. On average participants reported moderate levels of drug use (mean [<jats:italic>M<\/jats:italic>]\u2009=\u20093.25; <jats:italic>\u03b1<\/jats:italic>\u2009=\u20090.80), MMT (<jats:italic>M<\/jats:italic>\u2009=\u20093.24; <jats:italic>\u03b1<\/jats:italic>\u2009=\u20090.80), and HIV stigma (<jats:italic>M<\/jats:italic>\u2009=\u20092.94; <jats:italic>\u03b1<\/jats:italic>\u2009=\u20090.80). Anticipated drug use stigma from healthcare workers and internalized drug use stigma were significantly higher among PWID from Bishkek (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), while internalized HIV stigma among PWID living with HIV was significantly greater among PWID from Chuy Oblast (<jats:italic>p<\/jats:italic>\u2009=\u20090.03).\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The KISS cohort documents moderate levels of HIV-related intersectional stigma and suboptimal engagement in HIV prevention services among PWID in Kyrgyzstan. Future work will aim identify priority stigma reduction intervention targets to optimize HIV prevention efforts in the region.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-022-00633-5","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T11:03:04Z","timestamp":1653476584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cohort profile: the Kyrgyzstan InterSectional Stigma (KISS) injection drug use cohort study"],"prefix":"10.1186","volume":"19","author":[{"given":"Laramie R.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Shumskaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainura","family":"Kurmanalieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Werb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Blyum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel B.","family":"Algarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Yeager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Cepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"633_CR1","unstructured":"United Nations. Ending AIDS progress towards the 90\u201390\u201390 targets. Joint United Nations Programme on HIV\/AIDS; 2017. (Global AIDS updated)."},{"key":"633_CR2","unstructured":"United Nations. World Drug Report 2021 [Internet]. 2021 [cited 2022 Mar 8]. Available from: \/\/www.unodc.org\/unodc\/en\/data-and-analysis\/wdr2021.html"},{"key":"633_CR3","unstructured":"USAID. A study in the area of HIV in the Kyrgyz Republic. 2015. Available from: https:\/\/kyrgyzstan.un.org\/sites\/default\/files\/2019-09\/A%20study%20in%20HIV%20area%20in%20the%20Kyrgyz%20Republic%202015%20EN.pdf"},{"key":"633_CR4","unstructured":"UNAIDS. Kyrgyzstan | UNAIDS [Internet]. [cited 2022 Mar 8]. Available from: https:\/\/www.unaids.org\/en\/regionscountries\/countries\/kyrgyzstan"},{"key":"633_CR5","unstructured":"UNDP. Kyrgyzstan: reducing harm from HIV [Internet]. New York: United Nations development programme; 2018. Available from: https:\/\/www.kg.undp.org\/content\/kyrgyzstan\/en\/home\/ourwork\/democraticgovernance\/successstories\/kyrgyzstan--reducing-harm-from-hiv.html"},{"key":"633_CR6","volume-title":"HIV programme review in Kyrgyzstan: evaluation report, December 2014","author":"M Mansfeld","year":"2015","unstructured":"Mansfeld M, Ristola M, Likatavicius G. HIV programme review in Kyrgyzstan: evaluation report, December 2014. Regional Office for Europe: World Health Organization; 2015."},{"issue":"3","key":"633_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1108\/IJPH-03-2017-0016","volume":"14","author":"L Azbel","year":"2018","unstructured":"Azbel L, Wegman MP, Polonsky M, Bachireddy C, Meyer J, Shumskaya N, et al. Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments. Int J Prison Health. 2018;14(3):175\u201387.","journal-title":"Int J Prison Health"},{"key":"633_CR8","unstructured":"Gulgun Murzalieva, Aleshkina J, Adyl Temirov, Arnol Samiev, Nurzada Kartanbaeva, Jakab M, et al. Tracking global HIV\/AIDS initiatives and their impact on the health system: the experience of the Kyrgyz Republic [Internet]. Royal College of Surgeons in Ireland; 2019 [cited 2022 Mar 8] [868126 Bytes p.]. Available from: https:\/\/repository.rcsi.com\/articles\/Tracking_Global_HIV_AIDS_Initiatives_and_their_Impact_on_the_Health_System_the_experience_of_the_Kyrgyz_Republic\/10776524\/1"},{"issue":"1","key":"633_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-018-0274-2","volume":"16","author":"AP Deryabina","year":"2019","unstructured":"Deryabina AP, Patnaik P, El-Sadr WM. Underreported injection drug use and its potential contribution to reported increase in sexual transmission of HIV in Kazakhstan and Kyrgyzstan. Harm Reduct J. 2019;16(1):1.","journal-title":"Harm Reduct J"},{"issue":"7","key":"633_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1744-8603-7-22","volume":"13","author":"N Spicer","year":"2011","unstructured":"Spicer N, Bogdan D, Brugha R, Harmer A, Murzalieva G, Semigina T. \u201cIt\u2019s risky to walk in the city with syringes\u201d: understanding access to HIV\/AIDS services for injecting drug users in the former Soviet Union countries of Ukraine and Kyrgyzstan. Glob Health. 2011;13(7):22.","journal-title":"Glob Health"},{"issue":"8","key":"633_CR11","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1007\/s10461-013-0571-4","volume":"17","author":"A Smolak","year":"2013","unstructured":"Smolak A, El-Bassel N. Multilevel stigma as a barrier to HIV testing in Central Asia: a context quantified. AIDS Behav. 2013;17(8):2742\u201355.","journal-title":"AIDS Behav"},{"issue":"179","key":"633_CR12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.drugalcdep.2017.07.002","volume":"1","author":"A Deryabina","year":"2017","unstructured":"Deryabina A, El-Sadr WM. Uptake of needle and syringe program services in the Kyrgyz Republic: key barriers and facilitators. Drug Alcohol Depend. 2017;1(179):180\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"633_CR13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s11524-018-0256-4","volume":"95","author":"J Rozanova","year":"2018","unstructured":"Rozanova J, Morozova O, Azbel L, Bachireddy C, Izenberg JM, Kiriazova T, et al. Perceptions of health-related community reentry challenges among incarcerated drug users in Azerbaijan, Kyrgyzstan, and Ukraine. J Urban Health Bull N Y Acad Med. 2018;95(4):508\u201322.","journal-title":"J Urban Health Bull N Y Acad Med"},{"key":"633_CR14","unstructured":"Berger M. Workable sisterhood: a study of the political participation of stigmatized women with HIV\/AIDS [Internet]. University of Michigan; 1998 [cited 2022 Mar 8]. Available from: https:\/\/www.proquest.com\/docview\/304443683\/abstract\/8C43AF43806B41EBPQ\/1"},{"key":"633_CR15","first-page":"283","volume-title":"Black feminist thought: knowledge, consciousness, and the politics of empowerment","author":"PH Collins","year":"1990","unstructured":"Collins PH. Black feminist thought: knowledge, consciousness, and the politics of empowerment. 2nd ed. New York: Routledge; 1990. p. 283.","edition":"2"},{"issue":"6","key":"633_CR16","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.2307\/1229039","volume":"43","author":"K Crenshaw","year":"1991","unstructured":"Crenshaw K. Mapping the margins: intersectionality, identity politics, and violence against women of color. Stanf Law Rev. 1991;43(6):1241\u201399.","journal-title":"Stanf Law Rev"},{"issue":"3","key":"633_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3109\/09687637.2015.1016397","volume":"22","author":"MJ Bojko","year":"2015","unstructured":"Bojko MJ, Mazhnaya A, Makarenko I, Marcus R, Dvoriak S, Islam Z, et al. \u201cBureaucracy & beliefs\u201d: assessing the barriers to accessing opioid substitution therapy by people who inject drugs in Ukraine. Drugs Educ Prev Policy. 2015;22(3):255\u201362.","journal-title":"Drugs Educ Prev Policy"},{"issue":"11","key":"633_CR18","first-page":"1305","volume":"22","author":"MJ Mimiaga","year":"2010","unstructured":"Mimiaga MJ, Safren SA, Dvoryak S, Reisner SL, Needle R, Woody G. \u201cWe fear the police, and the police fear us\u201d: structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine. AIDS Care-Psychol Socio-Med Asp AIDSHIV. 2010;22(11):1305\u201313.","journal-title":"AIDS Care-Psychol Socio-Med Asp AIDSHIV"},{"issue":"4","key":"633_CR19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s10461-010-9793-x","volume":"15","author":"YA Amirkhanian","year":"2011","unstructured":"Amirkhanian YA, Kelly JA, Kuznetsova AV, DiFranceisco WJ, Musatov VB, Pirogov DG. People with HIV in HAART-era Russia: transmission risk behavior prevalence, antiretroviral medication-taking, and psychosocial distress. AIDS Behav. 2011;15(4):767\u201377.","journal-title":"AIDS Behav"},{"issue":"10","key":"633_CR20","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1007\/s10461-015-1282-9","volume":"20","author":"AV Kuznetsova","year":"2016","unstructured":"Kuznetsova AV, Meylakhs AY, Amirkhanian YA, Kelly JA, Yakovlev AA, Musatov VB, et al. Barriers and facilitators of HIV care engagement: results of a qualitative study in St. Petersburg, Russia. AIDS Behav. 2016;20(10):2433\u201343.","journal-title":"AIDS Behav"},{"issue":"5","key":"633_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/09540121.2016.1259451","volume":"29","author":"T Kiriazova","year":"2017","unstructured":"Kiriazova T, Lunze K, Raj A, Bushara N, Blokhina E, Krupitsky E, et al. \u201cIt is easier for me to shoot up\u201d: stigma, abandonment, and why HIV-positive drug users in Russia fail to link to HIV care. AIDS Care. 2017;29(5):559\u201363.","journal-title":"AIDS Care"},{"issue":"9","key":"633_CR22","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1007\/s10461-021-03172-5","volume":"25","author":"MV Vetrova","year":"2021","unstructured":"Vetrova MV, Cheng DM, Bendiks S, Gnatienko N, Lloyd-Travaglini C, Jiang W, et al. HIV and substance use stigma, intersectional stigma and healthcare among HIV-positive PWID in Russia. AIDS Behav. 2021;25(9):2815\u201326.","journal-title":"AIDS Behav"},{"issue":"1","key":"633_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10461-015-1100-4","volume":"20","author":"SK Calabrese","year":"2016","unstructured":"Calabrese SK, Burke SE, Dovidio JF, Levina OS, Uusk\u00fcla A, Niccolai LM, et al. Internalized HIV and drug stigmas: interacting forces threatening health status and health service utilization among people with HIV who inject drugs in St. Petersburg, Russia. AIDS Behav. 2016;20(1):85\u201397.","journal-title":"AIDS Behav"},{"issue":"10","key":"633_CR24","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1080\/09540121.2014.897910","volume":"26","author":"A Pecoraro","year":"2014","unstructured":"Pecoraro A, Mimiaga MJ, O\u2019Cleirigh C, Safren SA, Blokhina E, Verbitskaya E, et al. Lost-to-care and engaged-in-care HIV patients in Leningrad Oblast, Russian Federation: barriers and facilitators to medical visit retention. AIDS Care. 2014;26(10):1249\u201357.","journal-title":"AIDS Care"},{"issue":"Suppl 1","key":"633_CR25","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/S0376-8716(06)80010-4","volume":"82","author":"N Bobrova","year":"2006","unstructured":"Bobrova N, Rhodes T, Power R, Alcorn R, Neifeld E, Krasiukov N, et al. Barriers to accessing drug treatment in Russia: a qualitative study among injecting drug users in two cities. Drug Alcohol Depend. 2006;82(Suppl 1):S57-63.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"633_CR26","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1007\/s10461-013-0437-9","volume":"17","author":"VA Earnshaw","year":"2013","unstructured":"Earnshaw VA, Smith LR, Chaudoir SR, Amico KR, Copenhaver MM. HIV stigma mechanisms and well-being among PLWH: a test of the HIV stigma framework. AIDS Behav. 2013;17(5):1785\u201395.","journal-title":"AIDS Behav"},{"issue":"162","key":"633_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugalcdep.2016.02.019","volume":"1","author":"LR Smith","year":"2016","unstructured":"Smith LR, Earnshaw VA, Copenhaver MM, Cunningham CO. Substance use stigma: reliability and validity of a theory-based scale for substance-using populations. Drug Alcohol Depend. 2016;1(162):34\u201343.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"633_CR28","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/add.14799","volume":"115","author":"LR Smith","year":"2020","unstructured":"Smith LR, Mittal ML, Wagner K, Copenhaver MM, Cunningham CO, Earnshaw VA. Factor structure, internal reliability and construct validity of the Methadone Maintenance Treatment Stigma Mechanisms Scale (MMT-SMS). Addict Abingdon Engl. 2020;115(2):354\u201367.","journal-title":"Addict Abingdon Engl"},{"key":"633_CR29","unstructured":"Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review-ScienceDirect [Internet]. 2022 [cited 2022 Mar 8]. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0376871613000677"},{"key":"633_CR30","doi-asserted-by":"publisher","unstructured":"Woo J, Bhalerao A, Bawor M, Meha B, Dennis B, Mouravska N, et al. \u201cDon\u2019t judge a book by its cover\u201d: a qualitative study of methadone patients\u2019 experiences of stigma. Subst abuse [Internet]. 2017 [cited 2022 Mar 8]: [11p.]. Available from: https:\/\/journals.sagepub.com\/doi\/full\/https:\/\/doi.org\/10.1177\/1178221816685087","DOI":"10.1177\/1178221816685087"},{"issue":"1","key":"633_CR31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11469-012-9402-5","volume":"11","author":"V Earnshaw","year":"2013","unstructured":"Earnshaw V, Smith L, Copenhaver M. Drug addiction stigma in the context of methadone maintenance therapy: an investigation into understudied sources of stigma. Int J Ment Health Addict. 2013;11(1):110\u201322.","journal-title":"Int J Ment Health Addict"},{"issue":"5","key":"633_CR32","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/09540121.2016.1220485","volume":"29","author":"AM Nasarruddin","year":"2017","unstructured":"Nasarruddin AM, Saifi RA, Othman S, Kamarulzaman A. Opening up the HIV epidemic: a review of HIV seropositive status disclosure among people who inject drugs. AIDS Care. 2017;29(5):533\u201340.","journal-title":"AIDS Care"},{"issue":"6","key":"633_CR33","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.elerap.2010.07.003","volume":"9","author":"WJ Christopher","year":"2010","unstructured":"Christopher WJ. Lower bounds on sample size in structural equation modeling. Electron Commer Res Appl. 2010;9(6):476\u201387.","journal-title":"Electron Commer Res Appl"},{"key":"633_CR34","unstructured":"World Health Organization. HIV\/AIDS Programme in Kyrgyzstan [Internet]. 2015 [cited 2019 Oct 22]. Available from: https:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0005\/273308\/HIV-Programme-Review-in-Kyrgyzstan.pdf"},{"issue":"1","key":"633_CR35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12954-020-00435-7","volume":"17","author":"JP Meyer","year":"2020","unstructured":"Meyer JP, Culbert GJ, Azbel L, Bachireddy C, Kurmanalieva A, Rhodes T, et al. A qualitative study of diphenhydramine injection in Kyrgyz prisons and implications for harm reduction. Harm Reduct J. 2020;17(1):86.","journal-title":"Harm Reduct J"},{"issue":"6","key":"633_CR36","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","volume":"88","author":"JB Saunders","year":"1993","unstructured":"Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption\u2013II. Addict Abingdon Engl. 1993;88(6):791\u2013804.","journal-title":"Addict Abingdon Engl"},{"issue":"4","key":"633_CR37","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/01.qai.0000225020.73760.c2","volume":"42","author":"KR Amico","year":"2006","unstructured":"Amico KR, Fisher WA, Cornman DH, Shuper PA, Redding CG, Konkle-Parker DJ, et al. Visual analog scale of ART adherence: association with 3-day self-report and adherence barriers. J Acquir Immune Defic Syndr. 2006;42(4):455\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"633_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12916-019-1271-3","volume":"17","author":"AL Stangl","year":"2019","unstructured":"Stangl AL, Earnshaw VA, Logie CH, van Brakel W, Simbayi LC, Barr\u00e9 I, et al. The health stigma and discrimination framework: a global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas. BMC Med. 2019;17(1):31.","journal-title":"BMC Med"},{"issue":"6","key":"633_CR39","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1007\/s10461-009-9593-3","volume":"13","author":"VA Earnshaw","year":"2009","unstructured":"Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13(6):1160\u201377.","journal-title":"AIDS Behav"},{"issue":"2","key":"633_CR40","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s10461-017-2005-1","volume":"22","author":"KE Gamarel","year":"2018","unstructured":"Gamarel KE, Nelson KM, Stephenson R, Santiago Rivera OJ, Chiaramonte D, Miller RL. Anticipated HIV stigma and delays in regular HIV testing behaviors among sexually-active young gay, bisexual, and other men who have sex with men and transgender women. AIDS Behav. 2018;22(2):522\u201330.","journal-title":"AIDS Behav"},{"issue":"1","key":"633_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1477-7517-8-7","volume":"8","author":"T Volkmann","year":"2011","unstructured":"Volkmann T, Lozada R, Anderson CM, Patterson TL, Vera A, Strathdee SA. Factors associated with drug-related harms related to policing in Tijuana, Mexico. Harm Reduct J. 2011;8(1):7.","journal-title":"Harm Reduct J"},{"key":"633_CR42","doi-asserted-by":"publisher","first-page":"19043","DOI":"10.7448\/IAS.17.1.19043","volume":"17","author":"K Lunze","year":"2014","unstructured":"Lunze K, Raj A, Cheng DM, Quinn EK, Bridden C, Blokhina E, et al. Punitive policing and associated substance use risks among HIV-positive people in Russia who inject drugs. J Int AIDS Soc. 2014;17:19043.","journal-title":"J Int AIDS Soc"},{"issue":"6","key":"633_CR43","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1521\/aeap.2012.24.6.574","volume":"24","author":"VA Earnshaw","year":"2012","unstructured":"Earnshaw VA, Smith LR, Chaudoir SR, Lee I-C, Copenhaver MM. Stereotypes about people living with HIV: implications for perceptions of HIV risk and testing frequency among at-risk populations. AIDS Educ Prev Off Publ Int Soc AIDS Educ. 2012;24(6):574\u201381.","journal-title":"AIDS Educ Prev Off Publ Int Soc AIDS Educ"},{"issue":"1","key":"633_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19312458.2020.1718629","volume":"14","author":"AF Hayes","year":"2020","unstructured":"Hayes AF, Coutts JJ. Use omega rather than Cronbach\u2019s alpha for estimating reliability. But\u2026. Commun Methods Meas. 2020;14(1):1\u201324.","journal-title":"Commun Methods Meas"},{"issue":"3","key":"633_CR45","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/bjop.12046","volume":"105","author":"TJ Dunn","year":"2014","unstructured":"Dunn TJ, Baguley T, Brunsden V. From alpha to omega: a practical solution to the pervasive problem of internal consistency estimation. Br J Psychol Lond Engl. 2014;105(3):399\u2013412.","journal-title":"Br J Psychol Lond Engl"},{"issue":"6","key":"633_CR46","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1177\/0013164406288165","volume":"66","author":"JM Graham","year":"2006","unstructured":"Graham JM. Congeneric and (essentially) tau-equivalent estimates of score reliability: what they are and how to use them. Educ Psychol Meas. 2006;66(6):930\u201344.","journal-title":"Educ Psychol Meas"},{"key":"633_CR47","volume-title":"Overview of the methadone maintenance therapy in the Kyrgyz Republic","author":"A Usenakunova","year":"2021","unstructured":"Usenakunova A. Overview of the methadone maintenance therapy in the Kyrgyz Republic. Bishkek: The Republic Narcology Center; 2021."},{"key":"633_CR48","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.drugpo.2018.08.014","volume":"62","author":"A Davis","year":"2018","unstructured":"Davis A, McCrimmon T, Dasgupta A, Gilbert L, Terlikbayeva A, Hunt T, et al. Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan. Int J Drug Policy. 2018;62:43\u201350.","journal-title":"Int J Drug Policy"},{"issue":"6","key":"633_CR49","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3109\/10826081003590938","volume":"45","author":"A Sarang","year":"2010","unstructured":"Sarang A, Rhodes T, Sheon N, Page K. Policing drug users in Russia: risk, fear, and structural violence. Subst Use Misuse. 2010;45(6):813\u201364.","journal-title":"Subst Use Misuse"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-022-00633-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-022-00633-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-022-00633-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T11:10:19Z","timestamp":1653477019000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-022-00633-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["633"],"URL":"https:\/\/doi.org\/10.1186\/s12954-022-00633-5","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"assertion":[{"value":"2 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We obtained ethics approval for all study activities from the University of California, San Diego Institutional Review Board (IRB) and GLObal Research Institute (GLORI) Foundation IRB, Kyrgyzstan. Participants provided voluntary signed informed consent prior to participation in any study activities.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}